Maven Securities »

Crispr Therapeutics Ag call shares owned by Maven Securities

Quarter-by-quarter ownership of Crispr Therapeutics Ag call shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Crispr Therapeutics Ag call

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics Ag call held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics Ag call by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 18k 64.82

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Invesco Qqq Tr Put Put Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Ark Etf Tr Call Call Option
Newmont Corp Put Put Option
Nvidia Corporation Call Call Option
Eli Lilly & Co Put Put Option
Fedex Corp Call Call Option
Tesla Motors (TSLA)
Select Sector Spdr Tr Financial (XLF)

View all positions for Maven Securities

Top funds holding Crispr Therapeutics Ag call

IMC-Chicago
Group One Trading
Simplex Trading
Maven Securities
National Bank Of Canada /fi/
Hurley Capital
Advisor Group Holdings

View all funds holding Crispr Therapeutics Ag call